πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 169 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9290562

Transferrin-tumstatin fusion protein and methods for producing and using the same

The Regents of the University of Colorado Β· Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9259386

Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery int

Rani Therapeutics, LLC Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9200054

Somatostatin analogs with inhibitory activity to growth hormone release

The Regents of the University of California Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175041

Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9150533

Local cochlear application of statins for stimulating neurite regrowth in the cochlea

Northwestern University Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044518

Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8951754

Methods and materials for making simvastatin and related compounds

The Regents of the University of California Β· Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8933115

Stabilized statin formulations

Cumberland Pharmaceuticals Inc. Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8808679

Auristatin compounds and conjugates thereof

Mersana Therapeutics, Inc. Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8562948

Somatostatin analogs with inhibitory activity to growth hormone release

The Regents of the University of California Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8487097

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8404635

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8372877

Stabilized statin formulations

Cumberland Pharmaceuticals Inc. Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211664

Methods and materials for making simvastatin and related compounds

The Regents of the University of California Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080672

Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071638

Solid states of atorvastatin potassium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8063211

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the prepa

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8053416

Isolation and structure of turbostatins 1-4

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994178

Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994320

Narcistatin prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7968080

Somatostatin analogs with inhibitory activity to growth hormone release

The Regents of the University of California Β· Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7868169

Crystalline rosuvastatin intermediate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7820784

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816097

Nucleotide and protein sequence of Mammastatin and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted